Atlas Trials

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Clinical trial NCT02496988 · NOT_YET_RECRUITING

Trial details

NCT number
NCT02496988
Sponsor
The First People's Hospital of Changzhou
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Cytokine-Induced Killer CellsAdvanced Milignant Gliomas
Start date
2015-07-01
Primary completion
2028-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.